Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Joan Antón Puig-Butillé"'
Autor:
José Manuel González de Aledo-Castillo, Samira Serhir-Sgheiri, Neus Calbet-Llopart, Ainara Arcocha, Pedro Jares, Noemí Reguart, Joan Antón Puig-Butillé
Publikováno v:
Diagnostics, Vol 11, Iss 8, p 1319 (2021)
The cobas® EGFR Test provides a semiquantitative index (SQI) that reflects the proportion of mutated versus wild-type copies of the EGFR gene in plasma. The significance of SQI as an indirect measure of the variant allele frequency (VAF) or mutated
Externí odkaz:
https://doaj.org/article/ab9a31a3f42d4c24b6ae8058e5954bbd
Autor:
Joan Antón Puig-Butillé, Iván Victoria, Roxana Reyes, Cristina Sánchez, Noemi Reguart, José Manuel González de Aledo-Castillo, Ana Isabel Martinez-Puchol, Nuria Viñolas, Pedro Jares, Ainara Arcocha, Gabriel Felipe Rodríguez
Publikováno v:
J Thorac Dis
BACKGROUND: Analysis of circulating free DNA (cfDNA) by the real-time PCR cobas(®) EGFR Mutation Test v2 (cobas(®) EGFR Test) is a diagnostic approach used in clinical practice for the characterization of advanced non-small cell lung cancer (NSCLC)
Autor:
Esther Sanfeliu, Fara Brasó-Maristany, Maria Vittoria Dieci, Mercedes Marín-Aguilera, Blanca González-Farré, Gaia Griguolo, Tomas Pascual, Patricia Galván, Laura Angelats, Oleguer Castillo, Paula Blasco, Valeria Sirenko, Pedro Jares, Joan Antón Puig-Butillé, Laia Paré, Antonio Martínez, Antonio Llombart-Cussac, Javier Cortés, Ana Vivancos, Patricia Villagrasa, Joel S Parker, Charles M Perou, Aleix Prat, PierFranco Conte, Valentina Guarneri
Publikováno v:
Cancer Research. 83:P4-02
Background: The HER2DX assay is a genomic test in early-stage HER2-positive (HER2+) breast cancer that provides prognostic and predictive information. HER2DX is a supervised learning algorithm incorporating tumor size, nodal staging, and 4 gene expre
Autor:
Adela Rodríguez Hernández, Benedetta Conte, Laia Fernández, Fara Brasó-Maristany, Belén Pastor, Miriam Potrony, Lorena Moreno, Elia Grau, Joan Antón Puig-Butillé, Aurora Sánchez, Blanca González-Farré, Esther Sanfeliu, Olga Martínez-Sáez, Claudette Falato, Maria Vidal, Nuria Chic, Tomás Pascual, Francesco Schettini, Montserrat Muñoz, Francesc Balaguer, Aleix Prat, Barbara Adamo
Publikováno v:
Cancer Research. 83:P6-01
BACKGROUND: In early-stage triple negative breast cancer (TNBC), the addition of carboplatin (CBDCA) to neoadjuvant chemotherapy (CT) increases pathologic complete response (pCR) and relapsed-free survival. However, it is unclear whether CBDCA improv
Autor:
David Fuster, J M González de Aledo-Castillo, V Pastor, Noemí Reguart, Roxana Reyes, Pilar Paredes, Joan Antón Puig-Butillé, Nuria Viñolas, Sebastián Casanueva-Eliceiry, A. Soler-Perromat, Ivan Vollmer
Publikováno v:
European journal of nuclear medicine and molecular imaging. 48(11)
The aim of our study was to investigate the correlation between cfDNA concentration and fragment size fraction with FDG PET/CT- and CT-derived parameters in untreated NSCLC patient. Fifty-three patients diagnosed of locally advanced or metastatic NSC
Autor:
Andrea Vergara Gómez, Joan Antón Puig Butillé, Aitor Gastaminza Unanue, Esther Titos, Miguel Julián Martínez Yoldi, José Luis Villanueva-Cañas, Eva González-Roca
Current global pandemic due to the SARS-CoV-2 has struggled and pushed the limits of global health systems. Supply chain disruptions and scarce availability of commercial laboratory reagents have motivated worldwide actors to search for alternative w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1820bd5065f2d74be5ca427b6e88993
https://doi.org/10.1101/2020.06.11.140285
https://doi.org/10.1101/2020.06.11.140285
Autor:
Joan Antón Puig-Butillé, José Manuel González de Aledo-Castillo, Samira Serhir-Sgheiri, Pedro Jares, Noemí Reguart, Neus Calbet-Llopart, Ainara Arcocha
Publikováno v:
Diagnostics
Diagnostics, Vol 11, Iss 1319, p 1319 (2021)
Volume 11
Issue 8
Diagnostics, Vol 11, Iss 1319, p 1319 (2021)
Volume 11
Issue 8
The cobas® EGFR Test provides a semiquantitative index (SQI) that reflects the proportion of mutated versus wild-type copies of the EGFR gene in plasma. The significance of SQI as an indirect measure of the variant allele frequency (VAF) or mutated
Autor:
Iván Victoria, R. Molina Porto, Noemí Reguart, J.M. González De Aledo-Castillo, Ainara Arcocha, Joan Antón Puig-Butillé
Publikováno v:
Clinica Chimica Acta. 493:S570
Autor:
Andrea Elias-Mas, Miriam Potrony, Jaume Bague, David J. Cutler, Maria Isabel Alvarez-Mora, Teresa Torres, Tamara Barcos, Joan Anton Puig-Butille, Marta Rubio, Irene Madrigal, Susana Puig, Emily G. Allen, Laia Rodriguez-Revenga
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2023)
IntroductionFragile X-associated tremor/ataxia syndrome (FXTAS, OMIM# 300623) is a late-onset neurodegenerative disorder with reduced penetrance that appears in adult FMR1 premutation carriers (55–200 CGGs). Clinical symptoms in FXTAS patients usua
Externí odkaz:
https://doaj.org/article/2c323e1e817240288503176d3c886aa5
Autor:
Aleix Prat, Valentina Guarneri, Tomás Pascual, Fara Brasó-Maristany, Esther Sanfeliu, Laia Paré, Francesco Schettini, Débora Martínez, Pedro Jares, Gaia Griguolo, Maria Vittoria Dieci, Javier Cortés, Antonio Llombart-Cussac, Benedetta Conte, Mercedes Marín-Aguilera, Nuria Chic, Joan Anton Puig-Butillé, Antonio Martínez, Patricia Galván, Yi-Hsuan Tsai, Blanca González-Farré, Aurea Mira, Ana Vivancos, Patricia Villagrasa, Joel S. Parker, Pierfranco Conte, Charles M. Perou
Publikováno v:
EBioMedicine, Vol 75, Iss , Pp 103801- (2022)
Summary: Background: Both clinical and genomic data independently predict survival and treatment response in early-stage HER2-positive breast cancer. Here we present the development and validation of a new HER2DX risk score, and a new HER2DX patholog
Externí odkaz:
https://doaj.org/article/0fd537b853eb4d46994417b689144024